DISTRIBUTION SERVICES AGREEMENT BETWEEN SMITHKLINE BEECHAM CORPORATION AND ADOLOR CORPORATION DATED AS OF June 29, 2004Distribution Services Agreement • August 4th, 2004 • Adolor Corp • Pharmaceutical preparations
THIS DISTRIBUTION SERVICES AGREEMENT (this “Agreement”) is made and entered into as of the 29th day of June, 2004 (the “Effective Date”) by and between ADOLOR CORPORATION, a Delaware corporation having its principal office at 700 Pennsylvania Drive, Exton, Pennsylvania 19341 (“Adolor”) and SmithKline Beecham Corporation, a Pennsylvania corporation having its principal office at 200 North 16th Street, Philadelphia, Pennsylvania 19102 d/b/a GlaxoSmithKline (“GSK”). GSK and Adolor are sometimes referred to herein individually as a “Party” and collectively as “Parties.”
First Amendment to Consulting AgreementConsulting Agreement • August 4th, 2004 • Adolor Corp • Pharmaceutical preparations
This First Amendment to Consulting Agreement (“Amendment 1”) is made and entered into as of the 28th day of July, 2004 by and between Adolor Corporation, having its principal place of business at 700 Pennsylvania Drive, Exton, PA 19341 (“Adolor”) and Paul Goddard, Ph.D. (“Consultant”) located at 13502 Pierce Road, Saratoga, CA 95070.
API COMPOUND SUPPLY AGREEMENT between ADOLOR CORPORATION and GIRINDUS AG dated July 6, 2004Api Compound Supply Agreement • August 4th, 2004 • Adolor Corp • Pharmaceutical preparations • Pennsylvania
This API COMPOUND SUPPLY AGREEMENT (this “Agreement”), made as of the 6th day of July, 2004 (the “Effective Date”), between ADOLOR CORPORATION, a Delaware corporation having a principal place of business at 700 Pennsylvania Drive, Exton, Pennsylvania 19341 (“Adolor”), and GIRINDUS AG, a stock corporation organized under the laws of Germany, with a principal place of business at Postfach 100 259, Buchenallee 20, D-51402 Bensberg, Germany (“Supplier”). Adolor and Supplier may be referred to as a “Party” or, together, the “Parties”.
DRUG PRODUCT SUPPLY AGREEMENT between ADOLOR CORPORATION and PHARMACEUTICS INTERNATIONAL, INC. dated July 1, 2004Drug Product Supply Agreement • August 4th, 2004 • Adolor Corp • Pharmaceutical preparations • Delaware
This DRUG PRODUCT SUPPLY AGREEMENT (this “Agreement”), made as of the 1st day of July, 2004 (the “Effective Date”), between ADOLOR CORPORATION, a Delaware corporation having a principal place of business at 700 Pennsylvania Drive, Exton, Pennsylvania 19341 (“Adolor”), and PHARMACEUTICS INTERNATIONAL, INC., a Maryland corporation having a principal place of business at 10819 Gilroy Road, Hunt Valley, Maryland 21031 (“PII”). Adolor and PII may be referred to as a “Party” or, together, the “Parties”.
API COMPOUND SUPPLY AGREEMENT between ADOLOR CORPORATION and TORCAN CHEMICAL LTD. dated July 13, 2004Api Compound Supply Agreement • August 4th, 2004 • Adolor Corp • Pharmaceutical preparations • Pennsylvania
This API COMPOUND SUPPLY AGREEMENT (this “Agreement”), made as of the 13th day of July, 2004 (the “Effective Date”), between ADOLOR CORPORATION, a Delaware corporation having a principal place of business at 700 Pennsylvania Drive, Exton, Pennsylvania 19341 (“Adolor”), and Torcan Chemical Ltd., a corporation organized under the laws of the province of Ontario, having a principal place of business at P.O. Box 308, 110 Industrial Parkway North, Ontario, Canada L4G 3H4 (“Supplier”). Adolor and Supplier may be referred to as a “Party” or, together, the “Parties”.
AMENDMENT NO. 1 TO COLLABORATION AGREEMENTCollaboration Agreement • August 4th, 2004 • Adolor Corp • Pharmaceutical preparations
This Amendment No. 1 (“Amendment No. 1”) to the Collaboration Agreement dated as of April 14, 2002 by and between Adolor Corporation, a Delaware corporation, (“Adolor”) and Glaxo Group Limited, a United Kingdom corporation (“GSK”) (the “Collaboration Agreement”) is entered into as of the 22nd day of June, 2004 by and between Adolor and GSK and shall be effective as of June 24, 2003.
